Join
Live feed
·
INSIDERFilingvia Quantisnow
Albireo Pharma Inc. logo

SEC Form 4: Cooper Ronald Harold Wilfred sold $17,991 worth of shares (919 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 58,501 units (tax liability) (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.
ALBO· Albireo Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALBO (Albireo Pharma Inc.) and more on Quantisnow.